Polar Asset Management Partners’s AEON Biopharma AEON Stock Holding History

Polar Asset Management Partners’s Portfolio AEON Stock Details AEON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-38,371	Closed	-$1.49M	–	539
2024 Q4	$1.49M	Sell	38,371 -11,628	-23%	-$677K	0.02%	392
2024 Q3	$3.78M	Sell	49,999 -1,043	-2%	-$91.8K	0.08%	240
2024 Q2	$3.27M	Hold	51,042	–	–	0.07%	251
2024 Q1	$42.6M	Sell	51,042 -2,777	-5%	-$2.01M	0.73%	17
2023 Q4	$26.2M	Buy	+53,819	New	+$21.6M	0.45%	33
2021 Q4	–	Sell	-4,167	Closed	-$2.92M	–	1302
2021 Q3	$2.92M	Sell	4,167 -4,166	-50%	-$2.91M	0.03%	513
2021 Q2	$5.78M	Buy	+8,333	New	+$5.83M	0.06%	344

Other funds holding AEON

DIG

Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DCM

Dupont Capital Management Wilmington, Delaware $2.18M AUM 50.81% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Polar Asset Management Partners's AEON Position: Q1 2025 in Review

Polar Asset Management Partners sold out of AEON Biopharma (AEON) in Q1 2025, closing a stake of 38,371 shares — an estimated $1.49M sold.

Polar Asset Management Partners first reported a position in AEON in Q2 2021 and held it in 7 quarters. The position peaked at $42.6M in Q1 2024. 16 funds tracked by Wall St. Rank hold AEON as of Q1 2025.

Polar Asset Management Partners reported no remaining AEON Biopharma position as of Q1 2025 after selling out during the quarter.
Polar Asset Management Partners sold 38,371 AEON Biopharma shares in Q1 2025, an estimated $1.49M.
Polar Asset Management Partners first reported a position in AEON Biopharma in Q2 2021 and held it in 7 quarters.
Polar Asset Management Partners's AEON Biopharma position peaked at $42.6M in Q1 2024.
16 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2025.

Based on Polar Asset Management Partners's 13F filing for Q1 2025, filed 15 May 2025.